Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-02T23:07:37.328Z Has data issue: false hasContentIssue false

Epidural combination of ropivacaine with sufentanil for postoperative analgesia after total knee replacement: a pilot study

Published online by Cambridge University Press:  16 August 2006

S. Kampe
Affiliation:
University of Cologne, Department of Anaesthesiology and Intensive Care Medicine, Germany
C. Diefenbach
Affiliation:
University of Cologne, Department of Anaesthesiology and Intensive Care Medicine, Germany
B. Kanis
Affiliation:
University of Cologne, Department of Anaesthesiology and Intensive Care Medicine, Germany
M. Auweiler
Affiliation:
University of Cologne, Department of Anaesthesiology and Intensive Care Medicine, Germany
P. Kiencke
Affiliation:
University of Cologne, Departments of Medical Statistics, Cologne, Germany
K. Cranfield
Affiliation:
Royal Infirmary, Department of Anaesthesiology, Aberdeen, UK
Get access

Abstract

Background and objective: We assessed the analgesic efficacy of postoperative epidural infusions of ropivacaine 0.1 and 0.2% combined with sufentanil 1 μg mL−1 in a prospective, randomized, double-blinded study.

Methods: Twenty-two ASA I—III patients undergoing elective total-knee replacement were included. Lumbar epidural blockade using ropivacaine 0.75% was combined with either propofol sedation or general anaesthesia for surgery. After surgery, the epidural infusion was commenced. Eleven patients in each group received either an epidural infusion of ropivacaine 0.1% with 1 μg mL−1 sufentanil (Group 1) or ropivacaine 0.2% with 1 μg mL−1 sufentanil (Group 2) at a rate of 5–9 mL h−1. All patients had access to intravenous pirinatrimide (piritramide) via a patient-controlled analgesia (PCA) device.

Results: Motor block was negligible for the study duration in both groups. There was no significant difference with the 100 mm visual analogue scale (VAS) scores, with the consumption of rescue analgesia or with patient satisfaction. Patients in Group 1 experienced significantly less nausea (P < 0.05) than those in Group 2. Both treatment regimens provided effective postoperative analgesia with only a minimal use of supplemental opioid PCA.

Conclusions: We recommend the use of ropivacaine 0.1% with 1 μg mL−1 sufentanil for postoperative analgesia after total knee replacement as it provides efficient pain relief with no motor block of the lower limbs. In addition, compared with 0.2% ropivacaine with sufentanil, the mixture reduces local anaesthetic consumption without compromise in patient satisfaction or VAS scores. Patients even experience less nausea.

Type
Original Article
Copyright
2002 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)